Peanut Allergy Treatment Breakthrough

A World-First for Australian Children

Babies with peanut allergies in Australia are now being offered potentially life-changing treatment.

For the first time ever, babies with peanut allergies will be offered oral immunotherapy in Australia as part of a new standardised approach to treating the condition. The treatment, which is being offered at 10 paediatric hospitals across the country, has been shown to be highly effective in reducing the severity of peanut allergies and even preventing future reactions.

Peanut allergies are a serious and potentially life-threatening condition, affecting around 1 in 50 Australian children. The only way to prevent a reaction is to avoid peanuts and tree nuts completely. This can be very difficult, as peanuts and tree nuts are hidden ingredients in many foods.

The new treatment, known as oral immunotherapy, involves gradually introducing small amounts of peanut protein into the diet of a child with a peanut allergy. This is done under the supervision of a specialist allergist and is carefully monitored for any signs of an allergic reaction. Over time, the child's immune system becomes less sensitive to peanuts and they are able to tolerate larger amounts of peanut protein without experiencing a reaction.

The treatment is not a cure for peanut allergies, but it can significantly reduce the risk of a serious reaction. For many children, it can mean the freedom to enjoy foods that they would otherwise have to avoid. It can also give parents peace of mind, knowing that their child is less likely to have a life-threatening reaction to peanuts.

The new treatment is a world-first and is a major step forward in the management of peanut allergies. It is expected to have a significant impact on the lives of thousands of Australian children and their families.